News
1h
Zacks Investment Research on MSNSlowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human ...
The 17 members of a federal vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left the U.S. vaccine program critically weakened." The group, speaking ...
The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.
Cleveland health officials are warning residents after a 250% spike in COVID-19 viral levels was found in city wastewater.
Cleveland Department of Public Health officials are warning of a “strong likelihood of increased community spread in the ...
The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...
4d
Medindia on MSNFDA Approves ENFLONSIA to Shield Infants From RSVIn a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA (clesrovimab-cfor) , a ...
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...
Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...
First, let's back up a bit and take a look at the Moderna story, from the glory days of a few years ago to its troubles today ...
The new appointees include Vicky Pebsworth, a regional director for the National Association of Catholic Nurses. She has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results